Clinical trial
A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis…
NCT00420199 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00420199 |
|---|---|
| Title | A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate |
| Official title | A Phase IIIB Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Assess Short-term Changes in Synovitis and Structural Damage Outcomes in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate, Treated With Abatacept Versus Placebo on a Background Therapy… |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Active Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Abatacept, Placebo |
| Enrollment | 50 |
| Start date | May 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | May 1, 2010 |
| First posted | Jan 9, 2007 |
| Last update posted | Jan 18, 2012 |
| Countries | Belgium, Germany, Netherlands, Spain, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: